ストックスクリーナーアプリを入手
22.75
4.89%
1.06
アフターアワーズ：
22.75
前日終値:
$21.69
開ける：
$22.14
24時間の取引高:
838.59K
Relative Volume:
0.80
時価総額：
$1.30B
収益：
$2.25B
当期純損益:
$-1.18B
株価収益率:
-1.0994
EPS:
-20.6926
ネットキャッシュフロー:
$19.92M
1週間 パフォーマンス:
+2.89%
1か月 パフォーマンス:
-10.68%
6か月 パフォーマンス:
-25.02%
1年 パフォーマンス:
-40.46%
1日の値動き範囲:
$21.59
$22.87
1週間の範囲:
$21.48
$23.60
52週間の値動き範囲:
$21.00
$38.19
Enovis Corp Stock (ENOV) Company Profile
Compare ENOV vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ENOV
Enovis Corp
|
22.75 | 1.24B | 2.25B | -1.18B | 19.92M | -20.69 |
ABT
Abbott Laboratories
|
102.67 | 177.03B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
328.59 | 124.89B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.65 | 110.08B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.75 | 93.53B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
80.08 | 45.84B | 6.07B | 1.06B | 1.34B | 1.8063 |
Enovis Corp Stock (ENOV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-06 | 開始されました | BTIG Research | Buy |
| 2024-10-03 | 開始されました | JMP Securities | Mkt Outperform |
| 2024-06-13 | 開始されました | JP Morgan | Neutral |
| 2024-02-13 | 開始されました | Stephens | Overweight |
| 2024-01-22 | 開始されました | UBS | Buy |
| 2024-01-03 | 開始されました | William Blair | Outperform |
| 2023-12-15 | 繰り返されました | Needham | Buy |
| 2023-10-20 | 開始されました | ROTH MKM | Buy |
| 2023-06-26 | 開始されました | Needham | Buy |
| 2023-05-12 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-10-11 | 開始されました | Goldman | Buy |
| 2022-09-12 | 開始されました | Canaccord Genuity | Buy |
| 2022-09-12 | 開始されました | Evercore ISI | Outperform |
| 2022-06-28 | 開始されました | Argus | Hold |
| 2022-06-27 | 再開されました | Loop Capital | Buy |
| 2022-06-16 | 開始されました | Wells Fargo | Equal Weight |
すべてを表示
Enovis Corp (ENOV) 最新ニュース
Enovis Corporation (ENOV) Stock Price Quote Today & Current Price Chart - Capital.com
Breakout Zone: What is Enovis Corporations 5 year growth outlookMarket Sentiment Review & Consistent Profit Trade Alerts - baoquankhu1.vn
Trading Recap: What is Enovis Corporations 5 year growth outlookMarket Trend Report & Risk Controlled Daily Plans - baoquankhu1.vn
Enovis (NYSE:ENOV) Upgraded by Wall Street Zen to "Buy" Rating - MarketBeat
Enovis, Neogen, Humana, LifeStance Health Group, and Hims & Hers Health stocks trade down, what you need to know - MSN
Enovis, Neogen, Humana, LifeStance Health Group, and Hims & Hers Health Stocks Trade Down, What You Need To Know - Yahoo Finance
Press Release: Enovis Announces First Quarter 2025 Results - 富途牛牛
[SCHEDULE 13G/A] Enovis CORP Amended Passive Investment Disclosure - Stock Titan
Wall Street analysts see a 100.71% upside in Enovis (ENOV): Can the stock really move this high? - MSN
Enovis Delivers 7% Sales Growth in Q2, Raises Full-Year Outlook - MSN
DAVENPORT & Co LLC Cuts Stock Holdings in Enovis Corporation $ENOV - MarketBeat
Enovis Corporation (NYSE:ENOV) Q4 2025 earnings call transcript - MSN
Wall Street experts predict Enovis (ENOV) could climb by 100.71%: Is such a surge truly possible for the stock? - bitget.com
Wall Street Analysts See a 100.71% Upside in Enovis (ENOV): Can the Stock Really Move This High? - Yahoo Finance
Enovis (NYSE:ENOV) Stock Rating Lowered by Wall Street Zen - MarketBeat
Enovis Corporation (NYSE:ENOV) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
Tranche Update on Enovis Corporation's Equity Buyback Plan announced on February 16, 2018. - marketscreener.com
Wells Fargo Sticks to Its Buy Rating for Enovis (ENOV) - The Globe and Mail
Enovis (NYSE:ENOV) Rating Increased to Strong-Buy at Wells Fargo & Company - MarketBeat
UBS reiterates Enovis stock Buy rating on growth outlook By Investing.com - Investing.com Australia
UBS reiterates Enovis stock Buy rating on growth outlook - Investing.com
Enovis (ENOV) to report earnings tomorrow: Here is what to expect - MSN
Wells Fargo Maintains Enovis Corp(ENOV.US) With Buy Rating, Cuts Target Price to $42 - 富途牛牛
Signal Recap: Can Enovis Corporation maintain its current growth rate2026 Sector Review & Trade Opportunity Analysis - baoquankhu1.vn
Engert Oliver, chief administrative officer, buys Enovis Corp (ENOV) shares By Investing.com - Investing.com South Africa
Insider Buying: Oliver Engert Acquires Shares of Enovis Corp (EN - GuruFocus
Oliver Engert Buys 1,000 Shares of Enovis (NYSE:ENOV) Stock - MarketBeat
Engert Oliver, chief administrative officer, buys Enovis Corp (ENOV) shares - Investing.com
Enovis tops profit expectations but revenue falls short - MSN
[Form 4] Enovis CORP Insider Trading Activity - Stock Titan
Invenomic Capital Management LP Has $21.62 Million Holdings in Enovis Corporation $ENOV - MarketBeat
ENOV SEC FilingsEnovis Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Enovis Corporation $ENOV Stake Lowered by Dorsey Asset Management LLC - MarketBeat
How The Enovis (ENOV) Story Is Shifting Around Growth Margins And Cash Generation - Yahoo Finance
Enovis (NYSE:ENOV) Stock Rating Upgraded by Wall Street Zen - MarketBeat
ESAB,ENOV Options - Finviz
Engert Oliver, chief administrative officer at Enovis, buys $23,930 in ENOV By Investing.com - Investing.com South Africa
Enovis Corporation (ENOV): Orthopedic innovation and growth potential drive analyst confidence - MSN
Top Enovis Insider Makes Bold Move With Fresh Stock Purchase - TipRanks
Engert Oliver, chief administrative officer at Enovis, buys $23,930 in ENOV - Investing.com Australia
Enovis (ENOV) CAO Oliver Engert buys 1,000 shares in open-market trade - Stock Titan
Barclays PLC Lowers Stake in Enovis Corporation $ENOV - MarketBeat
Enovis (ENOV) Is Down 5.5% After 2025 Loss And 2026 Revenue Outlook UpdateHas The Bull Case Changed? - simplywall.st
Enovis (NYSE:ENOV) Insider Oliver Engert Purchases 750 Shares - MarketBeat
Enovis (ENOV) CFO awarded 47,974 RSUs as 3,167 shares withheld for taxes - Stock Titan
Enovis Corp (ENOV) 財務データ
収益
当期純利益
現金流量
EPS
2.03%
大文字化:
|
ボリューム (24 時間):